HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jones, E. L. Articles by Shen, Y. Search for Related Content PubMed PubMed Citation Articles by Jones, E. L. Articles by Shen, Y.

Ann Thorac Surg 1995;59:1397-1403
© 1995 The Society of Thoracic Surgeons

Should the Freehand Allograft Be Abandoned as a Reliable Alternative for Aortic Valve Replacement?

Divisions of Cardiothoracic Surgery, Cardiology, and Anesthesiology, Emory University School of Medicine, Atlanta, Georgia

Cryopreserved aortic allografts were used for aortic valve replacement in 80 patients between 1986 and 1994 (infracoronary in 46 and complete root replacement in 34). Hospital mortality was 6.3% (5/80) with all deaths occurring in the infracoronary group. Three of five deaths were in patients with endocarditis and valve ring abscess. Left ventricular-aortic mean pressure gradients across the allograft valves were significantly lower for root replacement patients (mean, 9.0 ± 6.9 mm Hg versus 18.1 ± 8.7 mm Hg for infracoronary patients) (p = 0.0001). No patient having root allograft replacement had early echocardiographic aortic insufficiency greater than grade 1 versus 28% of those having infracoronary implantations. Late aortic insufficiency of grade 2 or greater was seen in 46% of patients having infracoronary implantation versus 17% of patients having root implantation. Nine patients had explantation of an aortic allograft (eight infracoronary and one root). Reasons for explantation were as follows: endocarditis (three infracoronary, one root), technical (three infracoronary), undiagnosed idiopathic hypertrophic subaortic stenosis (1 patient), and prolapsing infracoronary leaflet (1 patient). Actuarial freedom from grade 3 and 4 aortic insufficiency or explantation was 77% at 7 years for infracoronary implantations. We conclude that the infracoronary aortic allograft has an unacceptable frequency of late insufficiency and its use in this position should be abandoned. The substantial incidence of late endocarditis in the infracoronary (freehand) aortic allograft was surprising. In aortic root allografts the progression to grade 2 valvular insufficiency (moderate) in 17% of patients by 22 months must be viewed with concern.

This article has been cited by other articles:

				A. Ali, Y. Abu-Omar, A. Patel, A. Y. Sheikh, Z. Ali, A. Saeed, A. Akhtar, T. Athanasiou, and J. Pepper Propensity analysis of survival after subcoronary or root replacement techniques for homograft aortic valve replacement. J. Thorac. Cardiovasc. Surg., February 1, 2009; 137(2): 334 - 341. [Abstract] [Full Text] [PDF]

				T. Athanasiou, C. Jones, R. Jin, G. L. Grunkemeier, and D. N. Ross Homograft Implantation Techniques in the Aortic Position: To Preserve or Replace the Aortic Root? Ann. Thorac. Surg., May 1, 2006; 81(5): 1578 - 1585. [Abstract] [Full Text] [PDF]

				A. P. Kappetein, J. Braun, L. H.B. Baur, A. Prat, K. Peels, M. G. Hazekamp, P. H. Schoof, and H. A. Huysmans Outcome and follow-up of aortic valve replacement with the freestyle stentless bioprosthesis Ann. Thorac. Surg., February 1, 2001; 71(2): 601 - 608. [Abstract] [Full Text] [PDF]

				K. M. Dossche, A. Brutel de la Riviere, W. J. Morshuis, M. A.A.M. Schepens, J. J.A.M. Defauw, and S. M. Ernst Cryopreserved aortic allografts for aortic root reconstruction: a single institution's experience Ann. Thorac. Surg., June 1, 1999; 67(6): 1617 - 1622. [Abstract] [Full Text] [PDF]

				F. M.E. Hoekstra, M. Witvliet, C. Y. Knoop, C. Wassenaar, A. J.J.C. Bogers, W. Weimar, and F. H.J. Claas Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies Ann. Thorac. Surg., December 1, 1998; 66(6): 2022 - 2026. [Abstract] [Full Text] [PDF]

				M. J. Eriksson, G.o. Kallner, S. Rosfors, T. Ivert, and L.-A. Brodin Hemodynamic performance of cryopreserved aortic homograft valves during midterm follow-up J. Am. Coll. Cardiol., October 1, 1998; 32(4): 1002 - 1008. [Abstract] [Full Text] [PDF]

				T. P. Willems, L. A. Van Herwerden, M. A. Taams, V. E. Kleyburg-Linker, J. R.T.C. Roelandt, and E. Bos Aortic allograft implantation techniques: pathomorphology and regurgitant jet patterns by doppler echocardiographic studies Ann. Thorac. Surg., August 1, 1998; 66(2): 412 - 416. [Abstract] [Full Text] [PDF]

				K. L. Gall, S. E. Smith, C. A. Willmette, and M. F. O'Brien Allograft Heart Valve Viability and Valve-Processing Variables Ann. Thorac. Surg., April 1, 1998; 65(4): 1032 - 1038. [Abstract] [Full Text] [PDF]

				J. R. Doty, J. D. Salazar, J. R. Liddicoat, J. H. Flores, and D. B. Doty Aortic Valve Replacement With Cryopreserved Aortic Allograft: Ten-Year Experience J. Thorac. Cardiovasc. Surg., February 1, 1998; 115(2): 371 - 380. [Abstract] [Full Text] [PDF]

				R. L. Prager, C. R. Fischer, B. Kong, J. P. Byrne, D. J. Jones, M. L. Hance, and O. Gago The Aortic Homograft: Evolution of Indications, Techniques, and Results in 107 Patients Ann. Thorac. Surg., September 1, 1997; 64(3): 659 - 663. [Abstract] [Full Text]